Old Web
English
Sign In
Acemap
>
authorDetail
>
Hans‐Peter Stobernack
Hans‐Peter Stobernack
Medicine
Letermovir
Pharmacokinetics
Diabetes mellitus
Internal medicine
4
Papers
99
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FRI-199-First in Human, single ascending dose clinical trial of AIC649 in patients with chronic hepatitis
2019
Journal of Hepatology
Ibironke Addy
Alen Jambrecina
Thomas Berg
Florian van Bömmel
Dirk Kropeit
Christiane Vank
Alexandra Bigge
Katja Nedoschinsky
Hans‐Peter Stobernack
Manickam Rangaraju
Silke Kummer
Urte Matschl
Adam J. Gehring
Johanna M. Eberhard
Marcus Altfeld
Julian Schulze zur Wiesch
Holger Zimmermann
Daniela Paulsen
Show All
Source
Cite
Save
Citations (6)
Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects
2018
Clinical pharmacology in drug development
Dirk Kropeit
Oliver von Richter
Hans‐Peter Stobernack
Helga Rübsamen‐Schaeff
Holger Zimmermann
Show All
Source
Cite
Save
Citations (49)
Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment
2017
British Journal of Clinical Pharmacology
Dirk Kropeit
David McCormick
Katharina Erb‐Zohar
Valentin S. Moiseev
Zhanna Kobalava
Hans‐Peter Stobernack
Holger Zimmermann
Helga Rübsamen‐Schaeff
Show All
Source
Cite
Save
Citations (21)
Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment
2017
British Journal of Clinical Pharmacology
Dirk Kropeit
Jürgen Scheuenpflug
Katharina Erb‐Zohar
Atef Halabi
Hans‐Peter Stobernack
Ellen Hulskotte
Arne Van Schanke
Holger Zimmermann
Helga Rübsamen‐Schaeff
Show All
Source
Cite
Save
Citations (23)
1